Ignite Creation Date:
2024-05-05 @ 4:40 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00291057
Status:
TERMINATED
Last Update Posted:
2013-12-23
First Post:
2006-02-10
Brief Title:
Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice
Sponsor:
Taro Pharmaceuticals USA
Organization:
Taro Pharmaceuticals USA
Organization Data
Organization:
Taro Pharmaceuticals USA
Class:
INDUSTRY
Study ID:
MALG-0508
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Taro Pharmaceuticals USA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Medical Director
Old Organization:
Taro Pharmaceuticals USA